|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Lantern Pharma (NASDAQ: LTRN) through any online brokerage.
The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by Colliers Securities on July 28, 2020. The analyst firm set a price target for 24.00 expecting LTRN to rise to within 12 months (a possible 64.72% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $14.57 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Lantern Pharma.
There is no upcoming split for Lantern Pharma.
Lantern Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.